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  Fifty three patients with renal cell carcinoma admitted to our hospital during the past
nineteen years were studied， mainly focusing on the factors that affect the survival rate．
The one year surviva｝ rates of male and female patients were 93 ％ and iOO％， respectively，
and the five year survival rates 63．6％ and 88．2％， respectively． The present study also
showed that erythrocyte sedimentation rate （ESR）， tumor weight， and pathological staging
were the important factors that affect the prognosis． Combined radiation and chemotherapy
tended to show a better survivai rate than chemotherapy alone．
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Fig． 4． Survival rates and tumor・weight
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Fig． 8． Survival rates and the adjuvant therapy
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